ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

COCH vs MYO // RETURN ON INVESTED CAPITAL (ROIC)

Envoy Medical Inc. (Class A) (NASDAQ) VS. Myomo Inc. (NYSE) • 15-METRIC TALLY: COCH 1 — MYO 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COCH VS. MYO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC COCH MYO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 65.70% -95.70 MYO /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -35.20% -24.80 MYO /operating-margins <GO>
Net Profit Margin -60.00% -38.10% -21.90 MYO /net-margins <GO>
Revenue Growth (YoY) 7.10% 25.70% -18.60 MYO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 3.62% 0.00% +3.62 COCH /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 MYO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.9 47.9 0.00 TIE /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $50.3M $51.5M -$1.2M MYO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR COCH REV MYO REV COCH GROSS % MYO GROSS % COCH FCF MYO FCF
FY 2025 $241.0K $40.9M -50.0% 65.7% -$18.4M -$16.3M
FY 2024 $225.0K $32.6M -50.0% 71.2% -$18.9M -$4.7M
FY 2023 $316.0K $19.2M — — -$17.1M -$6.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COCH // BETA —
MYO // BETA —